A randomized study comparing etoricoxib and diclofenac sodium in post hallux valgus surgery pain

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2010-020547-13-SE

Enrollment

200

Registered

2010-07-01

Start date

2011-08-24

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain MedDRA version: 12.1 Level: PT Classification code 10056350 Term: Pain management

Interventions

Trade Name: Arcoxia Product Name: Arcoxia Pharmaceutical Form: Tablet INN or Proposed INN: ETORICOXIB CAS Number: 0 Concentration unit: mg milligram(s) Concentration type: equal Concentration number:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient 18 - 70 years undergoing elective hallux valgus surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NSAID allergy sever/uncontrolled cardiovascular disease severe renal or hepatic disease

Design outcomes

Primary

Measure	Time frame
Main Objective: Study patients assessment of globbal satisfaction with pain medicatiion;Secondary Objective: Pain, ;Primary end point(s): Patients Global Evaluation of Study Medication	—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026